News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Schneyer Mark C.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/23/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $28.997, valued at
$290k
|
|
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/12/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 974 shares
@ $25.02, valued at
$24.4k
Exercised 1,893 restricted stock units
@ $0 |
|
05/19/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 15,310 shares
@ $22.5, valued at
$344.5k
Exercised 14,869 restricted stock units
@ $0 |
|
05/03/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Granted 89,936 options to buy
@ $21.75, valued at
$2M
Granted 27,259 restricted stock units
@ $0 |
|
02/27/2023 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 577 shares
@ $18.78, valued at
$10.8k
Exercised 1,353 restricted stock units
@ $0 |
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2022 |
4
| Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Granted 72,414 options to buy
@ $25.75, valued at
$1.9M
Granted 21,101 restricted stock units
@ $0 |
|
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2021 |
3
| Schneyer Mark C. (CFO) has filed a Form 3 on ACADIA PHARMACEUTICALS INC |
|
|